Clinical Outcomes of Patients With Variant Histology of Urothelial Carcinoma After Radical Cystectomy

Dan Bee Lee, Jae Yeon Kim, Yun Ha Lee, Won Hoon Song, Seung Soo Lee, Sungwoo Park, J. Nam
{"title":"Clinical Outcomes of Patients With Variant Histology of Urothelial Carcinoma After Radical Cystectomy","authors":"Dan Bee Lee, Jae Yeon Kim, Yun Ha Lee, Won Hoon Song, Seung Soo Lee, Sungwoo Park, J. Nam","doi":"10.22465/juo.234600400020","DOIUrl":null,"url":null,"abstract":"Purpose: The efficacy of standard chemotherapy or radical cystectomy in patients who have urothelial tumors with variant histology (VH) is very limited in terms of their prognosis. This study aimed to investigate the prognosis of bladder cancer (BC) patients with VH who underwent radical cystectomy (RC).Materials and Methods: We retrospectively evaluated 327 BC patients who underwent RC at Pusan National University Yangsan Hospital between February 2010 and June 2021. VH was categorized into less and more aggressive types according to the patient’s mortality risk relative to pure urothelial carcinoma (PUC). More aggressive types included micropapillary, plasmacytoid, and sarcomatoid variants. Less aggressive types comprised other variant types, including squamous differentiation, glandular differentiation, lipoid, and nested. Small cell carcinoma, pure adenocarcinoma, pure squamous cell carcinoma, and lymphoma BC were excluded from analysis. The progression-free survival (PFS) and overall survival (OS) rates were evaluated using Kaplan-Meier analysis and Cox regression.Results: After the exclusion of nonurothelial tumors, data from 299 patients were available for analysis. We identified 244 (74.6%) and 55 patients (16.8%) with PUC and urothelial carcinoma with VH, respectively. VH patients were categorized as having less aggressive (n=35) and more aggressive (n=20) types. Univariate analysis identified significant differences in PFS (p=0.031) between patients with PUC (n=244) and more aggressive VH (n=20). Multivariate analysis showed that more aggressive VH was significantly associated with OS and PFS. In the Kaplan-Meier analysis, a statistically significant difference was observed between PUC and more aggressive VH in OS and PFS.Conclusions: VH patients with more aggressive types showed more advanced TNM stages at presentation than PUC patients. Pathological upstaging after RC was more common in VH patients. Among VH patients, the presence of a more aggressive VH type can be an independent predictor of progression after RC, with a worse prognosis than that of PUC patients.","PeriodicalId":125788,"journal":{"name":"Journal of Urologic Oncology","volume":"13 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Urologic Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22465/juo.234600400020","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: The efficacy of standard chemotherapy or radical cystectomy in patients who have urothelial tumors with variant histology (VH) is very limited in terms of their prognosis. This study aimed to investigate the prognosis of bladder cancer (BC) patients with VH who underwent radical cystectomy (RC).Materials and Methods: We retrospectively evaluated 327 BC patients who underwent RC at Pusan National University Yangsan Hospital between February 2010 and June 2021. VH was categorized into less and more aggressive types according to the patient’s mortality risk relative to pure urothelial carcinoma (PUC). More aggressive types included micropapillary, plasmacytoid, and sarcomatoid variants. Less aggressive types comprised other variant types, including squamous differentiation, glandular differentiation, lipoid, and nested. Small cell carcinoma, pure adenocarcinoma, pure squamous cell carcinoma, and lymphoma BC were excluded from analysis. The progression-free survival (PFS) and overall survival (OS) rates were evaluated using Kaplan-Meier analysis and Cox regression.Results: After the exclusion of nonurothelial tumors, data from 299 patients were available for analysis. We identified 244 (74.6%) and 55 patients (16.8%) with PUC and urothelial carcinoma with VH, respectively. VH patients were categorized as having less aggressive (n=35) and more aggressive (n=20) types. Univariate analysis identified significant differences in PFS (p=0.031) between patients with PUC (n=244) and more aggressive VH (n=20). Multivariate analysis showed that more aggressive VH was significantly associated with OS and PFS. In the Kaplan-Meier analysis, a statistically significant difference was observed between PUC and more aggressive VH in OS and PFS.Conclusions: VH patients with more aggressive types showed more advanced TNM stages at presentation than PUC patients. Pathological upstaging after RC was more common in VH patients. Among VH patients, the presence of a more aggressive VH type can be an independent predictor of progression after RC, with a worse prognosis than that of PUC patients.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
根治性膀胱切除术后尿路上皮癌变异组织学患者的临床疗效
目的:就预后而言,标准化疗或根治性膀胱切除术对具有变异组织学(VH)的尿路上皮肿瘤患者的疗效非常有限。本研究旨在调查接受根治性膀胱切除术(RC)的变异组织学膀胱癌(BC)患者的预后情况:我们对 2010 年 2 月至 2021 年 6 月期间在釜山大学梁山医院接受根治性膀胱切除术的 327 例膀胱癌患者进行了回顾性评估。根据患者相对于纯尿路上皮癌(PUC)的死亡风险,VH 被分为侵袭性较低和侵袭性较高的类型。侵袭性较强的类型包括微乳头状癌、浆细胞状癌和肉瘤状癌。侵袭性较低的类型包括其他变异类型,包括鳞状分化型、腺分化型、类脂质型和巢状型。小细胞癌、纯腺癌、纯鳞癌和淋巴瘤 BC 不在分析之列。采用 Kaplan-Meier 分析法和 Cox 回归法评估了无进展生存期(PFS)和总生存期(OS):结果:排除非上皮肿瘤后,共有 299 名患者的数据可供分析。我们分别发现了 244 名(74.6%)和 55 名(16.8%)PUC 患者和伴有 VH 的尿路上皮癌患者。VH患者被分为侵袭性较低的类型(35人)和侵袭性较高的类型(20人)。单变量分析发现,PUC(244 人)和侵袭性较强的 VH(20 人)患者的 PFS 有显著差异(P=0.031)。多变量分析显示,侵袭性更强的 VH 与 OS 和 PFS 显著相关。在Kaplan-Meier分析中,PUC和侵袭性较强的VH患者在OS和PFS方面的差异具有统计学意义:结论:与PUC患者相比,侵袭性更强的VH患者在发病时TNM分期更晚。VH患者在RC后的病理分期更高。在VH患者中,侵袭性更强的VH类型是RC后病情进展的独立预测因素,其预后比PUC患者更差。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Role of Radiotherapy in Metastatic Renal Cell Carcinomas: An Evolutionary Journey in a Misunderstood Histological Type Influence of Body Composition on the Perioperative and Survival Outcomes of Renal Cell Carcinoma Early Experience With Pembrolizumab in Bacillus Calmette-Guérin Unresponsive Non–Muscle-Invasive Bladder Cancer Preoperative Renal Artery Embolization Before Radical Nephrectomy for Nonmetastatic Renal Cell Carcinoma: A Propensity Score Matched Analysis Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1